CA2772618C — Fatty acid niacin conjugates and their uses
Assigned to Astria Therapeutics Inc · Expires 2018-08-21 · 8y expired
What this patent protects
The invention relates to fatty acid niacin conjugates having a structure of Formula I: (see formula I) Compositions comprising an effective amount of such fatty acid niacin conjugates; and methods for treating or preventing a metabolic disease comprising the administration of an …
USPTO Abstract
The invention relates to fatty acid niacin conjugates having a structure of Formula I: (see formula I) Compositions comprising an effective amount of such fatty acid niacin conjugates; and methods for treating or preventing a metabolic disease comprising the administration of an effective amount of such fatty acid niacin conjugates are also provided.
Drugs covered by this patent
- Vascepa (ICOSAPENT ETHYL) · Amarin Pharms
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.